Collaborative Research (CORE) Group, Sydney, Australia; Department of Cardiothoracic Surgery, St George Hospital, Sydney, Australia; The Baird Institute for Applied Heart and Lung Surgical Research, Sydney, Australia.
Collaborative Research (CORE) Group, Sydney, Australia.
Lung Cancer. 2013 Sep;81(3):319-327. doi: 10.1016/j.lungcan.2013.04.024. Epub 2013 Jun 13.
Pleurectomy/decortication (P/D) in the treatment of malignant pleural mesothelioma includes a number of procedures with different clinical indications and therapeutic intents. To unify the nomenclature, IMIG and IASLC recently defined P/D-related procedures according to surgical technique, including 'extended P/D', 'P/D' and 'partial pleurectomy'. The present systematic review aimed to assess the safety and efficacy of these techniques.
A systematic review of relevant studies was performed by electronic search of five online databases from 1985 to 2012 by two independent reviewers according to predefined selection criteria.
Thirty-four studies involving 1916 patients who underwent pleurectomy were included for quantitative analysis. These included 12 studies on 'extended P/D', 8 studies on 'P/D' and 14 studies on 'partial pleurectomy'. Perioperative mortality ranged from 0% to 11% and perioperative morbidity ranged from 13% to 43%. Median overall survival ranged from 7.1 to 31.7 months and disease-free survival ranged from 6 to 16 months. One study reported on quality-of-life outcomes using a standardized questionnaire suggesting superior outcomes for 'extended P/D' compared to extrapleural pneumonectomy.
Results of the present systematic review suggested similar perioperative mortality outcomes between different P/D techniques but a trend towards higher morbidity and length of hospitalization for patients who underwent 'extended P/D'. However, overall and disease-free survival appeared to favour 'extended P/D' compared to less aggressive techniques. Future studies on P/D should adhere to recent definitions to enable accurate analysis of similar procedures. Direct comparisons of pleurectomy to extrapleural pneumonectomy remain challenging, and should be restricted to 'extended P/D' procedures only.
在恶性胸膜间皮瘤的治疗中,胸膜切除术/剥除术(P/D)包括许多具有不同临床适应症和治疗意图的手术程序。为了统一命名法,IMIG 和 IASLC 最近根据手术技术定义了与 P/D 相关的手术程序,包括“扩大 P/D”、“P/D”和“部分胸膜切除术”。本系统评价旨在评估这些技术的安全性和有效性。
通过两位独立审查员根据预设的选择标准,对五个在线数据库进行电子搜索,对相关研究进行了系统评价。
纳入了 1916 名接受胸膜切除术的患者的 34 项研究进行定量分析。这些研究包括 12 项关于“扩大 P/D”的研究、8 项关于“P/D”的研究和 14 项关于“部分胸膜切除术”的研究。围手术期死亡率范围为 0%至 11%,围手术期发病率范围为 13%至 43%。中位总生存期范围为 7.1 至 31.7 个月,无病生存期范围为 6 至 16 个月。一项研究报告了使用标准化问卷的生活质量结果,表明与额外胸膜切除术相比,“扩大 P/D”的结果更好。
本系统评价的结果表明,不同 P/D 技术之间的围手术期死亡率结果相似,但接受“扩大 P/D”的患者发病率和住院时间较长。然而,总体和无病生存期似乎有利于“扩大 P/D”与侵袭性较小的技术相比。未来的 P/D 研究应遵守最近的定义,以实现对类似手术程序的准确分析。胸膜切除术与额外胸膜切除术的直接比较仍然具有挑战性,并且应该仅限于“扩大 P/D”程序。